Investing

CareDx : CDNA

CDNA

Stock Data

$21.50

$0.69 (3.32%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

DIAGNOSTICS & RESEARCH

CareDx, Inc. specializes in creating diagnostic solutions tailored for transplant patients, offering a suite of products that monitor the health and acceptance of organ transplants. Their innovative offerings include AlloSure for kidney, heart, and lung transplant patients, which uses donor-derived cell-free DNA to detect organ rejection. Additionally, CareDx provides AlloMap Heart, a gene expression test for heart transplant recipients, and a range of HLA typing solutions like Olerup SSP and QTYPE. They also offer Ottr, a software for managing transplant patients, and AlloCare, a mobile app designed to support transplant recipients' journeys. Headquartered in South San Francisco, California, CareDx serves its products globally, directly and through distributors.

All CareDx Articles

2 Articles

Lee Jackson | Jun 17, 2023 at 6:05 AM EDT

5 of Cathie Wood’s Sizzling ARK Investment Stocks Are Buy Rated and Trading Under $10

These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential.…

Chris Lange | Jul 20, 2021 at 12:32 PM EDT

Apple, Array Tech, Vertex Pharma and More Tuesday Afternoon Analyst Calls

24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including Apple, Array…